Klein says he's personally not convinced these supplements even if the labels are accurate have been studied adequately enough in humans to show "the benefits outweigh any harm." As for the IV infusions, Pojednic points to data from her lab consisting of 14 people in total and another, similarly small study as evidence that they appear to be "quite safe," though NAD+ infusions did elicit a quite unpleasant experience, with "moderate to severe abdominal cramping, diarrhea, nausea, vomiting," according to her study
It is likely that skin injury and/or disease will alter aromatase promoter usage, as is the case in breast cancer where promoter usage switches to the cAMP responsive promoter [62]
PMID:8688086 [3] Jett L, Lger R, Thibaudeau K, et al
This peptide is used in laboratory research applications
NNMT NAD+, , SIRT1 SIRT3,
Consult your doctor if problems persist